347 related articles for article (PubMed ID: 12779015)
1. Adjuvant autologous tumour cell-lysate vaccine versus no adjuvant treatment in patients with M0 renal cell carcinoma after radical nephrectomy: 3-year interim analysis of a German multicentre phase-III trial.
Doehn Ch; Richter A; Lehmacher W; Jocham D
Folia Biol (Praha); 2003; 49(2):69-73. PubMed ID: 12779015
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy of renal cell carcinoma patients with an autologous tumor cell lysate vaccine: a 5-year follow-up analysis.
Repmann R; Goldschmidt AJ; Richter A
Anticancer Res; 2003; 23(2A):969-74. PubMed ID: 12820332
[TBL] [Abstract][Full Text] [Related]
3. Vaccine therapy in patients with renal cell carcinoma.
Van Poppel H; Joniau S; Van Gool SW
Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant autologous tumour cell vaccination in patients with renal cell carcinoma. Overall survival analysis with a follow-up period in excess of more than 10 years].
May M; Kendel F; Hoschke B; Gilfrich C; Kiessig S; Pflanz S; Seidel M; Brookman-Amissah S
Urologe A; 2009 Sep; 48(9):1075-83. PubMed ID: 19562320
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial.
Jocham D; Richter A; Hoffmann L; Iwig K; Fahlenkamp D; Zakrzewski G; Schmitt E; Dannenberg T; Lehmacher W; von Wietersheim J; Doehn C
Lancet; 2004 Feb; 363(9409):594-9. PubMed ID: 14987883
[TBL] [Abstract][Full Text] [Related]
6. Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinoma.
Schwaab T; Tretter C; Gibson JJ; Cole BF; Schned AR; Harris R; Wallen EM; Fisher JL; Waugh MG; Truman D; Stempkowski LM; Crosby NA; Heaney J; Ernstoff MS
J Urol; 2004 Mar; 171(3):1036-42. PubMed ID: 14767265
[TBL] [Abstract][Full Text] [Related]
7. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Blute ML; Cheville JC; Lohse CM; Frank I; Kwon ED; Weaver AL; Parker AS; Zincke H
Cancer; 2003 Apr; 97(7):1663-71. PubMed ID: 12655523
[TBL] [Abstract][Full Text] [Related]
8. Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma.
Doehn C; Esser N; Pauels HG; Kiessig ST; Stelljes M; Grossmann A; Jocham D; Drevs J
Eur Urol; 2009 Jul; 56(1):123-31. PubMed ID: 18550267
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answers.
Homicsko K; Berthold DR
Anticancer Drugs; 2011 Jan; 22 Suppl 1():S4-8. PubMed ID: 21173604
[TBL] [Abstract][Full Text] [Related]
10. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Marechal JM; Klotz L; Skinner E; Keane T; Claessens I; Sylvester R; ; ; ;
Eur Urol; 2007 Jun; 51(6):1606-15. PubMed ID: 17140723
[TBL] [Abstract][Full Text] [Related]
12. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma.
Sandhu SS; Symes A; A'Hern R; Sohaib SA; Eisen T; Gore M; Christmas TJ
BJU Int; 2005 Mar; 95(4):522-5. PubMed ID: 15705072
[TBL] [Abstract][Full Text] [Related]
13. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
Carini M; Minervini A; Lapini A; Masieri L; Serni S
J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma.
Steiner T; Knels R; Schubert J
Eur Urol; 2004 Sep; 46(3):327-30. PubMed ID: 15306102
[TBL] [Abstract][Full Text] [Related]
16. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
[TBL] [Abstract][Full Text] [Related]
17. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant interleukin-2, interferon-alpha, and 5-fluorouracil immunochemotherapy after radical nephrectomy for locally advanced renal cell carcinoma.
Hong SK; Kwak C; Lee SE
Urology; 2005 Sep; 66(3):518-22. PubMed ID: 16140069
[TBL] [Abstract][Full Text] [Related]
19. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
Iimura Y; Kihara K; Saito K; Masuda H; Kobayashi T; Kawakami S
Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
